randomisation sequence (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
randomisation sequence
Randomisation Sequence, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/randomisation+sequence/randomisation+sequence/pm25934300-611-58-28
Average 90 stars, based on 1 article reviews
Randomisation Sequence, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/randomisation+sequence/randomisation+sequence/pm25934300-611-58-28
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sequencing:Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Overall Low Low Unclear Unclear Low High Unclear Cochra ne review rating (78) Unclear Low Low Low Low Low High Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Chen Rater 1 Low: “AstraZeneca generated a Article Title: Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial Article Snippet: .. AstraZeneca generated a Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: .. Outcomes FEV1, VC, FVC, respiratory symptoms, exacerbations, chronic mucus hyper‐secretion, adverse events Notes Funding : AstraZeneca Identifier(s) : unknown Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Rater 2 Low: “AstraZeneca generated a Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta‐blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV 1 , VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta-blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV1, VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma Article Snippet: Published by John Wiley & Sons, Ltd. Tattersfield 2001 (Continued) drug consumption Funding AstraZeneca Notes - Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “Patients were randomly assigned to treatment groups in computer-generated blocks. .. The Generated:Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Overall Low Low Unclear Unclear Low High Unclear Cochra ne review rating (78) Unclear Low Low Low Low Low High Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Chen Rater 1 Low: “AstraZeneca generated a Article Title: Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial Article Snippet: .. AstraZeneca generated a Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: .. Outcomes FEV1, VC, FVC, respiratory symptoms, exacerbations, chronic mucus hyper‐secretion, adverse events Notes Funding : AstraZeneca Identifier(s) : unknown Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Rater 2 Low: “AstraZeneca generated a Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta‐blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV 1 , VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta-blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV1, VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma Article Snippet: Published by John Wiley & Sons, Ltd. Tattersfield 2001 (Continued) drug consumption Funding AstraZeneca Notes - Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “Patients were randomly assigned to treatment groups in computer-generated blocks. .. The Blocking Assay:Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Overall Low Low Unclear Unclear Low High Unclear Cochra ne review rating (78) Unclear Low Low Low Low Low High Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Chen Rater 1 Low: “AstraZeneca generated a Article Title: Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial Article Snippet: .. AstraZeneca generated a Article Title: Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal. Article Snippet: .. Quetiapine IR vs placebo for schizophrenia: Supplementary material Study Rater Sequence generation Allocation concealment Performance bias Detection bias Incomplete outcome data Selective reporting Other bias Rater 2 Low: “AstraZeneca generated a Selection:Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: .. Outcomes FEV1, VC, FVC, respiratory symptoms, exacerbations, chronic mucus hyper‐secretion, adverse events Notes Funding : AstraZeneca Identifier(s) : unknown Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta‐blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV 1 , VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease Article Snippet: .. Concomitant use of beta-blockers during the study was not allowed Outcomes Primary: spirometric indices (FEV1, VC, FVC) Secondary: respiratory symptoms (e.g. wheeze, wheeze without a cold, breathlessness at rest and at different grades of exertion, cough night and day, phlegm night and day, chest tightness), exacerbations, chronic mucus hypersecretion, adverse events Notes Funding: AstraZeneca Definition of pneumonia: not given Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Randomisation was masked and the Article Title: Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma Article Snippet: Published by John Wiley & Sons, Ltd. Tattersfield 2001 (Continued) drug consumption Funding AstraZeneca Notes - Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk “Patients were randomly assigned to treatment groups in computer-generated blocks. .. The |
Guillaumier 2018 " width="250" height="auto" />
Holliday 2019 " width="100%" height="100%">
Skelton 2022 " width="100%" height="100%">